The New Biomassters
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Who Will Control the Green Economy? ETC Group, 2011
!"#$%&''$(#)*+#'$*",$ -+,,)$.(#)#/01 23$4#5,+)/,)*3$6+,67+,$*#$37)(*&#)$7$-+,,) .(#)#/0 7*$8	:;<$.=>$-+#?6$6+#5&@,3$ 7)$?6@7*,$#)$(#+6#+7*,$6#%,+$7)@$ %7+)3$*"7*$*",$A?,3*$*#$(#)*+#'$B&#/733$ %&''$6,+6,*?7*,$*",$-+,,@ .(#)#/0C %%%C,*(4+#?6C#+4 “We are told by men of science that all the venture of mariners on the sea, all that counter-marching tribes and races that confounds old history with its dust and rumour, sprang from nothing more abstruse than the laws of supply and demand, and a certain natural instinct for cheap rations. To any one thinking deeply, this will seem a dull and pitiful explanation.” —Robert Louis Stevenson, Will o’ the Mill, 1901 “As long as the maximization of profit remains the cornerstone of acquisitive society and capitalist economy, corporations will retain their interest in scarcity as a creator of economic value.” —German-born economist, Erich W. Zimmermann, in World resources and industries: a functional appraisal of the availability of agricultural and industrial materials, 1933 2(D)#%',@4,/,)*3 All original artwork, including the cover illustration, “BioMassters: The Board Game,” and report design by Shtig. ETC Group gratefully acknowledges the financial support of SwedBio (Sweden), HKH Foundation (USA), CS Fund “Trickle Down” by Adam Zyglis used with permission. (USA), Christensen Fund (USA), Heinrich Böll Who Will Control the Green Economy? is ETC Group Foundation (Germany), the Lillian Goldman Charitable Communiqué no. 107. Trust (USA), Oxfam Novib (Netherlands) and the Norwegian Forum for Environment and Development. November 2011 ETC Group is solely responsible for the views expressed in All ETC Group publications are available free of charge this document. -
Putting the Cartel Before the Horse ...And Farm, Seeds, Soil, Peasants, Etc
Communiqué www.etcgroup.org September 2013 No. 111 Putting the Cartel before the Horse ...and Farm, Seeds, Soil, Peasants, etc. Who Will Control Agricultural Inputs, 2013? In this Communiqué, ETC Group identifies the major corporate players that control industrial farm inputs. Together with our companion poster, Who will feed us? The industrial food chain or the peasant food web?, ETC Group aims to de-construct the myths surrounding the effectiveness of the industrial food system. Table of contents Introduction: 3 Messages 3 Seeds 6 Commercial Seeds 7 Pesticides and Fertilizers 10 Animal pharma 15 Livestock Genetics 17 Aquaculture Genetics Industry 26 Conclusions and Policy Recommendations 31 Introduction: 3 Messages ETC Group has been monitoring the power and global reach of agro-industrial corporations for several decades – including the increasingly consolidated control of agricultural inputs for the industrial food chain: proprietary seeds and livestock genetics, chemical pesticides and fertilizers and animal pharmaceu- ticals. Collectively, these inputs are the chemical and biological engines that drive industrial agriculture. This update documents the continuing concentration (surprise, surprise), but it also brings us to three conclusions important to both peasant producers and policymakers… 1. Cartels are commonplace. Regulators have lost sight of the well-accepted economic principle that the market is neither free nor healthy whenever 4 companies control more than 50% of sales in any commercial sector. In this report, we show that the 4 firms / 50% line in the sand has been substan- tially surpassed by all but the complex fertilizer sector. Four firms control 58.2% of seeds; 61.9% of agrochemicals; 24.3% of fertilizers; 53.4% of animal pharmaceuticals; and, in livestock genetics, 97% of poultry and two-thirds of swine and cattle research. -
A Long Food Movement
A Long Food Movement: Transforming Food Systems by 2045 Lead authors: Pat Mooney, Nick Jacobs, Veronica Villa, Jim Thomas, Marie-Hélène Bacon, Louise Vandelac, and Christina Schiavoni. Advisory Group: Molly Anderson, Bina Agarwal, Million Belay, Jahi Chappell, Jennifer Clapp, Fabrice DeClerck, Matthew Dillon, Maria Alejandra Escalante, Ana Felicien, Emile Frison, Steve Gliessman, Mamadou Goïta, Shalmali Guttal, Hans Herren, Henk Hobbelink, Lim Li Ching, Sue Longley, Raj Patel, Darrin Qualman, Laura Trujillo-Ortega, and Zoe VanGelder. This text was approved by the IPES-Food panel and by ETC Group in March 2021. Citation: IPES-Food & ETC Group, 2021. A Long Food Movement: Transforming Food Systems by 2045. 2 Acknowledgements The lead authors were responsible for the development and drafting of this report through their participation in a Management Committee, under the leadership of Nick Jacobs (IPES- Food Director) and Pat Mooney (Project Lead, IPES-Food panel member and ETC Group co-founder). Research and editorial work was ably assisted by Anna Paskal in the final stages. Throughout the project, the Management Committee has been guided by the contributions of a 21-member Advisory Group, drawn from various world regions and civil society constituencies (including Indigenous peoples, peasant organizations, food workers, and youth climate activists) as well as from multilateral institutions, many scientific disciplines, and business. Although these experts have contributed extensively to guiding the analysis, their participation in the Advisory Group does not imply full validation of the report or specific ideas therein. The management committee would like to thank Advisory Group members for their invaluable commitment and expertise. They are also grateful to the full IPES-Food panel, which has played a key role in shaping and developing this project, and the full ETC Group team for their many research and review contributions, especially Neth Daño and Zahra Moloo. -
What Is Synthetic Biology?
ETC Group Heinrich Böll Stiftung ...works to address the socioeconomic Fostering democracy and upholding and ecological issues surrounding new human rights, taking action to prevent technologies that could have an impact the destruction of the global ecosystem, on the world’s poorest and most advancing equality between women and vulnerable people. We investigate men, securing peace through conflict ecological erosion (including the erosion prevention in crisis zones, and defending of cultures and human rights); the the freedom of individuals against development of new technologies excessive state and economic power – (especially agricultural but also other these are the objectives that drive the technologies that work with genomics ideas and actions of the Heinrich Böll and matter); and we monitor global Foundation. We maintain close ties to governance issues including corporate the German Green Party (Alliance 90 / concentration and trade in technologies. The Greens) and as a think tank for We operate at the global political level. green visions and projects, we are part of We work closely with partner civil an international network encompassing society organizations (CSOs) and social well over 100 partner projects in movements, especially in Africa, approximately 60 countries. Asia and Latin America. The Heinrich Böll Foundation works www.etcgroup.org independently and nurtures a spirit of intellectual openness. We maintain a Extreme Biotech Meets Extreme Energy worldwide network with currently is ETC communique #113. 32 international offices. We cooperate closely with 16 state-level Böll Original Research by ETC Group with Foundations in each of Germany’s the financial support and collaboration federal states, and we support talented, of the Heinrich Böll Foundation. -
PA00XCSB.Pdf
Leidos Proprietary 1. EXECUTIVE SUMMARY A summary of efforts for the planned, ongoing, and completed projects for the Malaria Vaccine Development Program (MVDP) contract for this reporting period are herein detailed. A compiled Gantt chart including activities associated with each of the projects has been created and included as an attachment to this report. Ongoing projects that will continue through FY2019 include two vaccine development projects, the CSP vaccine development project (CSP Vaccine) and liver stage vaccine development project (Liver Stage Vaccine), as well as the clinical study with RH5 (RH5.1 Clinical Study), the latter to assess long-term immunogenicity in RH5.1/AS01 vaccinees. Of note is that while both the CSP and the liver stage vaccine development projects were initiated as epitope-based projects, these have since been realigned to target whole proteins; therefore, the project names have also been realigned to remove “epitope-based.” Expansion of work on the RCR complex into a vaccine development project (RCR Complex) occurred in early FY2019 and this project will continue until the end date of the contract. Lastly, a new project, the RH5.1 human monoclonal antibody identification and development project (RH5.1 Human mAb), was initiated in early FY2019 and will continue until the end date of the contract. Two projects were completed in FY2019, the blood stage epitope-based vaccine development project and the PD1 blockade inhibitor project (PD1 Block Inh). Leidos continues to seek collaborators for information exchange under NDA, reagent exchange under MTA, and collaboration under CRADA, to expand our body of knowledge and access to reagents with minimal cost to the program. -
Synthetic Genomics and Synthetic Biology Applications Between Hopes and Concerns
Send Orders of Reprints at [email protected] Current Genomics, 2013, 14, 11-24 11 Synthetic Genomics and Synthetic Biology Applications Between Hopes and Concerns 1,2, 1 1 1 Harald König *, Daniel Frank , Reinhard Heil and Christopher Coenen 1Institute for Technology Assessment and Systems Analysis (ITAS); 2Institute of Toxicology and Genetics (ITG), Karlsruhe Institute of Technology, PO box 3640, 76021 Karlsruhe, Germany Abstract: New organisms and biological systems designed to satisfy human needs are among the aims of synthetic ge- nomics and synthetic biology. Synthetic biology seeks to model and construct biological components, functions and or- ganisms that do not exist in nature or to redesign existing biological systems to perform new functions. Synthetic genom- ics, on the other hand, encompasses technologies for the generation of chemically-synthesized whole genomes or larger parts of genomes, allowing to simultaneously engineer a myriad of changes to the genetic material of organisms. Engi- neering complex functions or new organisms in synthetic biology are thus progressively becoming dependent on and con- verging with synthetic genomics. While applications from both areas have been predicted to offer great benefits by mak- ing possible new drugs, renewable chemicals or clean energy, they have also given rise to concerns about new safety, en- vironmental and socio-economic risks – stirring an increasingly polarizing debate. Here we intend to provide an overview on recent progress in biomedical and biotechnological applications of synthetic genomics and synthetic biology as well as on arguments and evidence related to their possible benefits, risks and governance implications. Received on: May 22, 2012- Revised on: October 11, 2012- Accepted on: October 12, 2012 Keywords: Applications, Benefits, Biofuels, Biomedicine, Environment, Risks, Synthetic genomics, Synthetic biology. -
After Seven Years As the UK Government's Chief Scientific Adviser
Interview What David did next After seven years as the UK government’s chief scientific adviser, chemist David King is still fighting to keep climate change at the top of the political agenda. Richard Van Noorden meets him Ask scientists who has been ‘We’re now centre of Oxford,’ he explains, influence in getting the subject so most responsible for making UK referring to the Foresight high on the UK government agenda. politicians pay attention to the seeing an programmes he established while ‘Coming into government from science of climate change, and enormous advising government, where the university sector was certainly many would nominate Sir David ministers were encouraged to leave a very steep learning curve,’ he says. King – from 2000–2007, the widely effort into aside short-term political interests ‘Nobody should ever underestimate respected chief scientific adviser of the biggest and scan a longer-term horizon to the problem of keeping science, and Tony Blair’s Labour government. tackle societal issues from flooding an understanding of what science can After seven years ensuring that challenge of our to obesity. deliver, on the government’s agenda’. policy-makers had access to the best time’ ‘And instead of being marginalised Among King’s successes were the science, the South African-born in a single department, we will agreement that each government chemist has time to reflect on his get climate change mainstreamed department has its own scientific experiences now he has returned to … there will be lecturers in adviser, and he also played a large the relative freedom of academia. -
Commissioned Papers Synthetic Genomics: Risks and Benefits For
Commissioned Papers Synthetic Genomics: Risks and Benefits for Science and Society This volume of papers accompanies the report Synthetic Genomics: Options for Governance Synthetic Genomics: Risks and Benefits for Science and Society (this page blank) Synthetic Genomics: Risks and Benefits for Science and Society COMMISSIONED PAPERS TABLE OF CONTENTS Robert Jones Sequence Screening……………………………………………………………...……1-16 Yogesh Sanghvi A Roadmap to the Assembly of Synthetic DNA from Raw Materials……..………….17-33 Ralph S. Baric Synthetic Viral Genomics…………………………………………………………….35-81 Marc S. Collett Impact of Synthetic Genomics on the Threat of Bioterrorism with Viral Agents..………………………………………………………………………..83-103 Diane O. Fleming Risk Assessment of Synthetic Genomics: A Biosafety and Biosecurity Perspective………………………...………………………………….105-164 Franco Furger From Genetically Modified Organisms to Synthetic Biology: Legislation in the European Union, in Six Member Countries, and in Switzerland…………………………………………………………..……..165-184 Synthetic Genomics: Risks and Benefits for Science and Society (this page blank) Synthetic Genomics: Risks and Benefits for Science and Society The following papers were commissioned for the project Synthetic Genomics: Risks and Benefits for Science and Society. These papers formed the basis of many discussions at project workshops and at a large invitational meeting. The information elicited from these meetings, and from the commissioned papers themselves, formed the basis of our report Synthetic Genomics: Options for Governance (http://dspace.mit.edu/handle/1721.1/39141). The views and opinions expressed in these commissioned papers are those of the authors of the papers and not necessarily those of the authors of the report, or of the institutions at which the authors work. Citation: Working Papers for Synthetic Genomics: Risks and Benefits for Science and Society. -
SUSTAINABLE PHILANTHROPY an Essay By
Page 1 of 81 SUSTAINABLE PHILANTHROPY an essay by Andy Turnbull [email protected] TABLE OF CONTENTS TABLE OF CONTENTS .......................................................................................1 SUSTAINABLE PHILANTHROPY .......................................................................2 FINDING WATER ................................................................................................8 RUNNING OUT OF DIRT? ................................................................................15 TERRA PRETA ..................................................................................................20 CLIMATE CHANGE ..........................................................................................22 OTHER PROBLEMS .........................................................................................39 GLOBALIZATION ..............................................................................................40 OUR OPTIONS .................................................................................................46 FOOD FOR THE FUTURE ................................................................................49 THE GREEN REVOLUTION COULD BE A TRAP .............................................50 TO AVOID THE TRAP .......................................................................................53 MEAT ANIMALS ...............................................................................................56 BIG FARMS ARE A BIG HAZARD ....................................................................63 -
Xenobiology: a New Form of Life As the Ultimate Biosafety Tool Markus Schmidt* Organisation for International Dialogue and Conflict Management, Kaiserstr
Review article DOI 10.1002/bies.200900147 Xenobiology: A new form of life as the ultimate biosafety tool Markus Schmidt* Organisation for International Dialogue and Conflict Management, Kaiserstr. 50/6, 1070 Vienna, Austria Synthetic biologists try to engineer useful biological search for alternatives. They belong to apparently very systems that do not exist in nature. One of their goals different science fields and their quest for biochemical is to design an orthogonal chromosome different from diversity is driven by different motivations.(1–3) The science DNA and RNA, termed XNA for xeno nucleic acids. XNA exhibits a variety of structural chemical changes relative fields in question include four areas: origin of life, exobiology, to its natural counterparts. These changes make this systems chemistry, and synthetic biology (SB). The ancient novel information-storing biopolymer ‘‘invisible’’ to nat- Greeks, including Aristotle, believed in Generatio spontanea, ural biological systems. The lack of cognition to the the idea that life could suddenly come into being from non- natural world, however, is seen as an opportunity to living matter on an every day basis. Spontaneous generation implement a genetic firewall that impedes exchange of genetic information with the natural world, which means of life, however, was finally discarded by the scientific it could be the ultimate biosafety tool. Here I discuss, why experiments of Pasteur, whose empirical results showed that it is necessary to go ahead designing xenobiological modern organisms do not spontaneously arise in nature from systems like XNA and its XNA binding proteins; what non-living matter. On the sterile earth 4 billion years ago, the biosafety specifications should look like for this however, abiogenesis must have happened at least once, genetic enclave; which steps should be carried out to boot up the first XNA life form; and what it means for the eventually leading to the last universal common ancestor society at large. -
HIP Brief History of the Internet of Things and the Elusive Quest to Measure Performance
HIP Brief History of the Internet of Things and the Elusive Quest to Measure Performance Shoumen Palit Austin Datta MIT Auto-ID Labs, Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA MDPnP Lab, Department of Anesthesiology, Massachusetts General Hospital, Harvard Medical School, Cambridge, MA Center for Robots & Sensors in Human Well Being, School of Engineering Technology, Purdue University, W. Lafayette, IN ABSTRACT Performance is a purveyor for the progress of civilization. Progress is synonymous with improvement, efficiency and a general sense of being or building better than before. Quantification of states before and after are indicators of the value of performance, which, if positive, may constitute tangible (physical, procedural) or intangible (moral sentiments, security) contribution toward progress. Social and scientific tools to measure performance are a part of our historical progress. In the past few centuries frameworks and tools have been developed. In the 20th century electrification, automobiles, computation and connectivity accelerated our pace of progress. In the 21st century even more tools and technologies are attempting to measure many different aspects of performance. This brief essay is an attempt to selectively discuss a few of these concepts and how they relate to performance measurements. Here we consider the underlying concept of connectivity and how it has germinated the ideas we refer to as the internet of things (IoT), context awareness and the interaction between percepts, environment, actuators and sensors (PEAS). The complexity of these related domains and their convergence shapes performance. Measurement of isolated parts may offer an incomplete glimpse of performance but that is all which is possible, at present. -
IGF-II) Gene in Villus During 610 Gestational Weeks, Jianhong Chen, Qun Fang, Baojiang Chen, Yi Zhou, and Yanmin Luo Volume 2010, Article ID 965905, 4 Pages
Obstetrics and Gynecology International Epigenetic Regulation in Reproductive Medicine and Gynecologic Cancers Guest Editors: Shi-Wen Jiang, Brian Brost, Sean Dowdy, Xing Xie, and Fan Jin Epigenetic Regulation in Reproductive Medicine and Gynecologic Cancers Obstetrics and Gynecology International Epigenetic Regulation in Reproductive Medicine and Gynecologic Cancers Guest Editors: Shi-Wen Jiang, Brian Brost, Sean Dowdy, Xing Xie, and Fan Jin Copyright © 2010 Hindawi Publishing Corporation. All rights reserved. This is a special issue published in volume 2010 of “Obstetrics and Gynecology International.” All articles are open access articles distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Obstetrics and Gynecology International Editorial Board Sean Blackwell, USA Howard D. Homesley, USA Faustino R. Perez-L´ opez,´ Spain Diane C. Bodurka, USA Shi-Wen Jiang, USA Tonse N.K. Raju, USA Curt W. Burger, The Netherlands Marc J. N. C. Keirse, Australia Neal S. Rote, USA Linda D. Cardozo, UK Russell K. Laros Jr., USA Giovanni Scambia, Italy Nancy Chescheir, USA Jonathan Ledermann, UK Peter E. Schwartz, USA Robert Coleman, USA Kimberly K. Leslie, USA John J. Sciarra, USA W. T. Creasman, USA Lawrence D. Longo, USA J. L. Simpson, USA Mary E. D’Alton, USA G. A. Macones, USA Anil Sood, USA Gian Carlo Di Renzo, Italy Everett Magann, USA Wiebren A. A. Tjalma, Belgium Keith A. Eddleman, USA James A. McGregor, USA J. R. Van Nagell, USA Edmund F. Funai, USA Liselotte Mettler, Germany John M. G. van Vugt, The Netherlands Norbert Gleicher, USA Daniel R.